Deutsch English Français

Contact

EP1893236

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1893236

EP1893236 - DIRECT COMPRESSION FORMULATION OF DPP-IV INHIBITORS AND GLITAZONES, AND PROCESS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 28.06.2013 Database last updated on 06.11.2024
Most recent event Tooltip	28.06.2013	Application deemed to be withdrawn	published on 31.07.2013 [2013/31]
Applicant(s)	For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH
	For:AT Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT
	[N/P]
Former [2009/43]	For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH
	For:AT Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT
Former [2008/10]	For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH
	For:AT NOVARTIS-PHARMA GMBH Brunner Strasse 59 1230 Vienna / AT
Inventor(s)	01 / KOWALSKI, James 3727 Symes Drive Belle Mead, NJ 08502 / US
	02 / LAKSHMAN, Jay Parthiban 215 Vista Drive Cedar Knolls, NJ 07927 / US
	03 / PATEL, Arun P. 10 East Maple Avenue Succasunna, NJ 07876 / US
	[2008/10]
Representative(s)	(deleted)
	[2010/43]
Former [2009/25]	Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Leopoldstrasse 4 80802 München / DE
Former [2009/08]	Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Leopoldstrasse 4 80802 München / DE
Former [2008/10]	Ligibel, Jean-Marc Novartis AG Corporate Intellectual Property 4002 Basel / CH
Application number, filing date	06772588.7	08.06.2006
	[2008/10]
	WO2006US22336
Priority number, date	US20050689739P	10.06.2005 Original published format: US 689739 P
	US20050690527P	14.06.2005 Original published format: US 690527 P
	US20050690814P	15.06.2005 Original published format: US 690814 P
	[2008/10]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2006135693
	Date:	21.12.2006
	Language:	EN
	[2006/51]
	Type:	A2 Application without search report
	No.:	EP1893236
	Date:	05.03.2008
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 21.12.2006 takes the place of the publication of the European patent application.
	[2008/10]
Search report(s)	International search report - published on:	EP	15.02.2007
Classification	IPC:	A61K45/06, A61K31/40, A61K31/4439, A61K9/20	[2008/10]
	CPC:	A61K31/40 (EP,KR,US); A61K31/4439 (EP,KR,US); A61K45/06 (EP,KR,US); A61K9/20 (KR); A61P3/08 (EP); A61P3/10 (EP); (+) A61P43/00 (EP) (-)
	C-Set:	A61K31/40, A61K2300/00 (EP,US); A61K31/4439, A61K2300/00 (US,EP)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/10]
Extension states	AL	Not yet paid
	BA	Not yet paid
	HR	Not yet paid
	MK	Not yet paid
	RS	Not yet paid
Title	German:	DIREKTDRUCKFORMULIERUNG UND -VERFAHREN	[2008/10]
	English:	DIRECT COMPRESSION FORMULATION OF DPP-IV INHIBITORS AND GLITAZONES, AND PROCESS	[2008/10]
	French:	FORMULATION A COMPRESSION DIRECTE ET PROCEDE	[2008/10]
Entry into regional phase	10.01.2008	National basic fee paid
	10.01.2008	Designation fee(s) paid
	10.01.2008	Examination fee paid
Examination procedure	10.01.2008	Examination requested [2008/10]
	22.10.2009	Despatch of a communication from the examining division (Time limit: M06)
	02.01.2013	Application deemed to be withdrawn, date of legal effect [2013/31]
	20.02.2013	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2013/31]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 22.10.2009
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the examination report
	20.08.2010	Request for further processing filed
	20.08.2010	Full payment received (date of receipt of payment) Request granted
	09.09.2010	Decision despatched
Fees paid	Renewal fee
	12.06.2008	Renewal fee patent year 03
	16.06.2009	Renewal fee patent year 04
	28.06.2010	Renewal fee patent year 05
	13.06.2011	Renewal fee patent year 06
	Penalty fee
	Additional fee for renewal fee
	30.06.2012	07 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[Y]EP0861666 (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [Y] 1-7,9-17,20-45,48-51,54-60,63,64,67,68,70-72 * page 10, lines 24-31; examples 1-3 *;
		[DXYI]WO0152825 (NOVARTIS AG [CH], et al) [DX] 1-7,10,18-24,31,32,34,37-41,49-56,58-64,67-70 * page 30, paragraph 3; examples 1-5; claims 1,2,4-7,10,11,14-16; tables 1,7,8 * * page 32, line 3 * [Y] 1-7,9-17,20-45,48-51,54-60,63,64,67,68,70-72 [I] 8,9,12-17,25-30,33,57,65,66,71;
		[I]WO02083128 (BRISTOL MYERS SQUIBB CO [US], et al) [I] 1-20,38,40,49,51-57,60-69 * page 20, lines 7-24; claim 15 * * page 32, lines 11-32 *;
		[XI]WO2005032590 (TAKEDA PHARMACEUTICAL [JP], et al) [X] 1-7,9-11,17,18,20-24,31-34,36-42,45,46,48,67-69 * the whole document * [I] 25-30,43,44,47,49-66,70-72;
		[I]US2005101637 (STAPPER CHRISTIAN [DE], et al) [I] 1 * paragraphs [0276] , [0283] - [0285]; claim 6 *;
		[PX]WO2006047248 (NOVARTIS AG [CH], et al) [PX] 1-9,11,16,18-24,31-35,37-41,49,52-54,58-72 * page 34, paragraph 3; claim 25 * * page 38; table . * * page 40; example . *;
		EP1671649 [ ] (TAKEDA PHARMACEUTICAL [JP]) [ ] * paragraphs [0049] , [0059] - [0063] - [0065] , [0078] , [0094] - [0096]; example 1 *;
		[A] - BURKEY B F ET AL, "Combination Treatment of a DPP-IV Inhibitor NVP-LAF237 with Pioglitazone Completely Normalized Glucose Tolerance in Adult Obese Zucker Rats", DIABETES, NEW YORK, NY, US, (2002), vol. 51, no. sup2, ISSN 0012-1797, pages A338 - A339, XP009061638 [A] 1-71

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p